GPAR

GPAR predicts drug mechanisms of action (MOAs) from drug-induced gene expression profiles using deep learning to enable mechanistic inference and hypothesis generation.


Key Features:

  • Deep learning integration: Applies deep learning and machine learning algorithms to model relationships between gene expression changes and drug MOAs.
  • Drug-induced gene expression profiling: Uses large-scale drug-induced gene expression profiles as input for MOA modeling and prediction.
  • Customizable training sets: Trains models on user-defined/customized datasets to focus on specific biological questions or drug classes.
  • Performance evaluation and prediction: Evaluates model performance with cross-validation and reports improved MOA prediction relative to Gene Set Enrichment Analysis (GSEA).

Scientific Applications:

  • Drug repurposing: Predicts MOAs to identify potential new therapeutic applications for existing compounds.
  • Hypothesis generation for experimental validation: Generates mechanistic hypotheses from gene expression–based MOA predictions to guide follow-up experiments.
  • High-throughput gene expression analysis: Analyzes large-scale/high-throughput gene expression datasets for systematic investigation of drug-induced biological effects.

Methodology:

Queries drug-induced gene expression profiles and applies deep learning/machine learning algorithms to train models on customized datasets, with model evaluation performed via cross-validation.

Topics

Details

Tool Type:
web application
Added:
3/19/2021
Last Updated:
3/30/2021

Operations

Publications

Gao S, Han L, Luo D, Liu G, Xiao Z, Shan G, Zhang Y, Zhou W. Modeling drug mechanism of action with large scale gene-expression profiles using GPAR, an artificial intelligence platform. BMC Bioinformatics. 2021;22(1). doi:10.1186/s12859-020-03915-6. PMID:33413089. PMCID:PMC7788535.

PMID: 33413089
PMCID: PMC7788535
Funding: - This work is supported by National Natural Science Foundation of China: 81803431